What is the Birth Control Pill?
The Birth Control Pill is any drug which uses artificial
hormones to
keep a woman from getting pregnant or from staying pregnant by
interfering
with her normal fertility.
Are all forms of the Pill the same?
No. There are several types of the Pill on the market,
but they basically
break down into two groups: combination pills and the progestin-only
"minipill."
The combination type contain two artificial steroids
that mimic the
effects of naturally occurring hormones, estrogen and progesterone.
Some
pills work in a "monophasic" way, keeping the dosage of hormones the
same
throughout the pill cycle. Others work in a biphasic or triphasic
manner
which alters the dosage of artificial hormones two or three times
respectively
through the cycle of pills, attempting to produce fluctuations similar
to what a fertile woman would undergo naturally.
The progestin-only "minipill" uses only one artificial
hormone, progestin,
which is a steroid that has a progestational effect similar to natural
progesterone.
How does the Pill work?
The Pill is designed to interfere with several normal
functions of fertility
in order to make a woman 1) unable to conceive due to temporary
sterility
or sperm immobility, and/or 2) unable to carry a pregnancy to term(an
early
abortion). This process can be accomplished in various ways.
1. Suppressing Ovulation: When a woman
ovulates, hormones released
from the pituitary , a gland located at the base of the brain,
stimulate
her ovaries to ripen and release an egg. The combination pill
usually
interrupts the release of these pituitary hormones resulting in no egg
being released from the ovary, thus preventing pregnancy from
occurring.
With no egg available for fertilization, the woman is chemically
sterile.
The progestin-only pill, however, has a weaker effect. It
generally
does not suppress ovulation.1
2. Inhibiting Implantation: Another important
aspect of fertility
is the process by which the lining of the uterus is replenished and
maintained.
After an egg is fertilized, it normally implants in this lining
(endometrium),
drawing nourishment and sustenance. The progestin component of the
combination
pill and the progestin-only minipill cause the inner lining of the
uterus
to become thin and shriveled, unable to support implantation of the
embryo(newly
fertilized egg).2
3. Impeding Sperm Migration: Preceding
ovulation, a woman’s cervix
produces a watery mucus through which sperm swim to meet the egg. The
mucus
also provides nourishment to sustain the life of the sperm cells. This
mucus thickens under the influence of a progestin and so impedes sperm
migration.3
There are two other factors in a woman’s fertility that
may be affected
by the Pill.
4. Making changes in the Fallopian Tubes:
Progestins lower the
efficiency with which the fallopian tubes propel eggs from the ovaries
toward the uterus. This can cause the embryo not to reach the uterus in
time to implant successfully.4
5. Stopping a Pregnancy: After an ovary releases
an egg, the
woman’s cycle is controlled by a gland that is formed from the
now-empty
egg sack, the corpus luteum; this normally functions long
enough
to give an embryo time to implant in the uterus and for the placenta to
begin to support the pregnancy.
However, hormones from the Pill can cause the corpus
luteum to function
inadequately, allowing the lining of the uterus to be shed before the
embryo
can successfully implant.5
In summary, a woman’s natural fertility requires several
systems and
organs to coordinate smoothly. The synthetic chemicals in any type of
birth
control Pill interfere with this coordination, adversely affecting her
normal fertility and any "accidental" conceptions.
How effective is the Pill?
In theory, the Pill reaches an effectiveness of over
99%, but in practice
the rate is much lower. Between 1.9% and 18.1% of women will experience
an unplanned pregnancy in the first year of using the Pill.6
Surprise pregnancies with the Pill are due to a number
of factors. Interactions
between the Pill and some other medications interfere with the proper
blood
levels of hormones necessary for their birth control effect. These drug
interactions may be significant with the commonly used "low dose" Pill
where slight alterations in hormonal blood levels can result in more
frequent
ovulations and hence unplanned pregnancies. Another factor in Pill
pregnancy
rates is not following directions, sometimes due to the lack of
motivation,
especially in younger women (ages 15-24).
Is ovulation always suppressed?
No. Ovulation occurs in 2% to 10% of cycles of women
taking the Pill.7,8,9,10,11,12,13
If 60 million women worldwide are on the low-dose Pill, there would be
1.2 to 6 million ovulations per cycle. This is known as breakthrough
ovulation,
and it is even more frequent with the progestin-only Pill.14,15
What happens when ovulation does occur?
When the Pill fails to prevent ovulation, the other
mechanisms come
into play. Thickened cervical mucus may make it more difficult for the
sperm to reach the egg; however, if the egg is fertilized, a new life
is
created. The hormones slow the transfer of the new life through the
fallopian
tube, and the embryo may become too old to be viable when it does enter
the uterus.
If the embryo is still viable when it reaches the
uterus, under-development
of the uterine lining caused by the Pill prevents implantation. The
embryo
dies and the remains are passed along in the next bleeding episode
which,
incidentally, is not a true menstruation even though it is usually
perceived
as such.
Does this mean the Pill can cause an early abortion?
Yes. Preventing the newly conceived life in its
embryonic stage from
being transported to the uterus and preventing implantation in the wall
of the uterus are the "abortifacient" properties of the Pill.
How
often does the Pill cause abortions?
Why haven’t I heard
about this before?
The Pill manufacturers and many in organized medicine
are mainly concerned
about the Pill’s medical side effects and its effectiveness in
preventing
pregnancies and are less concerned about how the drug achieves its
effectiveness.
Unfortunately, many "otherwise" pro-life physicians and
pharmacists
find it hard to admit that these abortifacient properties exist because
they would have to discontinue prescribing and dispensing the Pill if
they
were to remain consistent in their respect for life at all its stages
of
development.
Pro-abortion organizations and their lawyers readily
admit the early
abortion potential of the Pill. In February 1992, writing in opposition
to a Louisiana law banning abortion, Ruth Colker, a Tulane Law School
professor,
wrote, "Because nearly all birth control devices, except the diaphragm
and condom, operate between the time of conception...and
implantation..,
the statute would appear to ban most contraceptives."16 In
1989,
attorney Frank Sussman argued before the U. S. Supreme Court that ". .
. IUDs [and] low dose birth control pills. . . act as abortifacients."17
Is It Safe?
What are the common side effects of the Pill?
There is a range of risks from serious or fatal to minor
and trivial.
The following is a list of the most common side effects experienced by
women taking the Pill. These effects are dose related and not every
woman
will experience them, but the risks still exist.18,19 The
synthetic
estrogens of the combination Pill cause many of these; the progestin
causes
others and is the only risk factor in the progestin-only Pill (and the
progestin-only implant, Norplant).
Heart and blood abnormalities
Blood Clots can form, restricting or blocking the
flow of blood
to critical organs and other body systems, possibly causing permanent
damage.
For example, a blood clot in the heart would cause a heart attack; in
the
brain it would cause a stroke or brain hemorrhage; a clot which moved
from
elsewhere in the body and lodged in the lung would cause a pulmonary
embolism;
in the kidneys a clot would cause a renal artery thrombosis and kidney
damage; in the retinal arteries it would cause temporary or permanent
blindness.
Studies continue to indicate approximately a 2-fold
increased risk of
fatal heart attacks among users of the current low-dose pill when
compared
to non-users.20 This risk is lower than the risk experienced
with the older high dosage pill, but it continues to be significant.
Similarly,
the risk of a fatal brain hemorrhage is increased 1.4 times when
comparing
users to non-users. Among women who smoke, there is a 12-fold increase
in fatal heart attacks and a 3.1-fold increase in fatal brain
hemorrhage.21
High Blood Pressure and alterations in the blood
clotting mechanisms
may be seen in women on the Pill.22 This may contribute to a
3-11 times increased risk of developing blood clots in Pill users
compared
to non-users. The risk is especially great for women who smoke and/or
are
over 35 years old.23
Cancer
Breast cancer has been repeatedly associated with
using the Pill.24,25,26,27,28,29,30,31
Breast cancer has been increasing at an alarming rate in
recent years,
especially among young women. "Breast cancer will kill more than 44,000
American women this year alone," a 1991 report noted,32
predicting
175,000 more new cases, "especially among young women."
Why is there such an increase of breast cancer among
younger women?
Note first that women rarely develop breast cancer shortly after they
start
taking artificial hormones. It is generally not until ten or more years
after usage was initiated that women develop breast cancer. Then note
that
in the United States, since the mid-1970s, it has been common for the
Pill
to be prescribed for girls in their teen years. Common sense connects
the
link between giving the Pill to young girls in the 1970s and the later
increase in breast cancer 15 to 20 years later among women in their
late
twenties and thirties. This conclusion was demonstrated in a study
which
found that Swedish women who took the Pill in the 1960s incurred a five
times greater increase in breast cancer when compared to non-users.33
The increased risk of breast cancer is seen in younger,
nulliparous
women (never having borne children), and in long duration groups
(greater
than five years) of Pill users. Large tumors and a worse survival rate
are associated with the Pill’s use at an early age.
Will the newer formulated low-dose pills decrease the
incidence of breast
cancer? A consensus of understanding has not been reached, and another
10 to 20 years of experience with women using this form of the Pill
must
be gained before more definite conclusions can be reached.
Breast tenderness, enlargement, lumps, and milk
secretions also may
occur in women using the Pill. Doctors are warned not to prescribe the
Pill to women who are "known or suspected" to have breast cancer.34
It is difficult to say what aggravating effect the Pill’s hormones
would
have over a truly random sample of women taking the Pill.
Cervical Cancer and cervical dysplasia increase
among women who
use the Pill.35,36,37,38,39 How long the Pill has been
taken,
how many sexual partners a woman has had, at what age she began having
intercourse, whether she smokes, the hygiene of sexual partners and the
transmission of the human papillomavirus(HPV) are also factors in
cervical
abnormalities. Because of these several factors, the connection of the
Pill and cervical cancer may be clouded over. However, there is no
doubt
that the promotion of the Pill has resulted in early intercourse which
may be the more direct cause of cervical cancer.
Endometrial and Ovarian Cancer appear to have a
lower incidence
in both women on the Pill and in those who have been previous users of
the Pill. Much of this data comes from studies of women who were using
the higher dose estrogen/progestin Pill. Currently the low dose
monophasic
and triphasic pills (less than 50mcg of estrogen) are the only birth
control
pills available on the U.S. market. It is not known if a similar
protective
effect will be experienced with the currently used Pill. More time is
needed
to study this issue, and the slight protective effect is hardly a
reason
to take the Pill at the risk of so many other side effects.
It should also be noted that these forms of cancer are
rare and primarily
occur among postmenopausal women in their fifties and sixties. Second,
these cancers tend to occur in those women who had long cycles (i.e.,
with
a prolonged estrogen-dominant phase) or those who have a family history
of these types of cancer. Third, extended breastfeeding amenorrhea
offers
the same type of protection against these cancers since the menstrual
cycle
would be suppressed and therefore the exposure to estrogen suppressed.
Liver Tumors in younger women (15 to 40 years)
have increased
as the use of oral contraceptives has increased. Almost unheard of in
this
age group before the use of synthetic hormones became commonplace,
liver
tumors usually do not occur until the sixth decade of a woman’s life.
A study by the American College of Surgeons’ Commission
on Cancer found
"a large peak in the 26-to-30-year age group which corresponds with the
increased use of oral contraceptives in this age group."40
Liver
cancer in women on the Pill is typically associated with those over 30
who have used it more than four years, but cases of liver cancer in
younger
women have been cited.41,42,43,44
Other Cancers: Skin cancer (melanoma) has also
been found to
increase among women on the Pill. Naturally occurring estrogen is
involved
with maintaining healthy skin tissue. It is reasonable to suspect that
exposure to the more potent synthetic estrogen in the Pill increases
the
risk of this type of cancer.45,46,47
Cycle irregularities
Women who take the Pill have been reported to experience bleeding or
spotting
in mid-cycle, changes in menstrual flow, and even loss of menstruation,
which can lead them to wonder if they are pregnant. For some, painful
menstruation
(dysmenorrhea) has been reported to worsen, even though many women take
these hormones in an attempt to relieve the problem.48
Although some women are given the Pill for irregular
cycles, it does
nothing to improve the underlying problem causing the irregularity.
Often
the irregularity returns when the Pill is discontinued, sometimes more
severely.
Are there other side effects?
Yes. Some side effects are minor while some may be more
severe and call
for discontinuing the drug.49,50,51
The following adverse effects have been experienced by
women on the
Pill:
Headaches, migraines, mental depression (even to the
point of suicide
and/or suicidal tendencies), a decrease or loss of sexual drive,
abdominal
cramps, bloating, weight gain or loss, and water retention; nausea and
vomiting(in about 10% of users); symptoms of PMS, vaginitis and vaginal
infections, changes in vision (temporary or permanent blindness, and an
intolerance to contact lenses); gall bladder disease and either
temporary
or permanent infertility, when discontinuing the Pill, in users with
previous
menstrual irregularities or who began the drug before full maturity.
Several
of the symptoms, such as migraine headaches, contraindicate the use of
the Pill because of life endangering complications.
Consult the Physicians’ Desk Reference at your
public library
or consult your pharmacist for a more complete list of the Pill’s
harmful
effects.
Is the Pill safer than pregnancy?
No. The health risks of the Pill outweigh by far the
risks of pregnancy
and childbirth to a woman’s health,52 and any claim to the
contrary
is based on erroneous comparisons between healthy women on the Pill and
women who do not receive normal care during pregnancy.
A precondition for obtaining the Pill is routine medical
care and checkups.
For example: if such a woman on the Pill is diagnosed as
"precancerous,"
or if some other side effect is exhibited, she has the advantage of
early
detection. However, many pregnant women do not receive routine medical
care. A clearer picture of the safety of the Pill compared to the
safety
of pregnancy would be made if healthy women receiving routine medical
care
during pregnancy and delivery were compared with women receiving
routine
medical care while taking the Pill.
The mortality statistics of childbirth have continuously
declined since
the early part of this century, mostly due to better maternal
healthcare.53
Most of the high risk pregnancies and deliveries occur to women who
have
not sought proper medical attention.54 This is most evident
in the Third World where adequate health care is sparse.
Mortality statistics of pregnancy and delivery, usually
called maternal
mortality, include the mortality rates due to abortion. Abortion is
clearly
used as birth control, preventing the birth of the child; therefore it
must be included with the mortality statistics of birth control
methods.
In one study, 25% to 50% of the reported maternal mortality was a
result
of deaths from abortion.55
Fifty percent of woman taking the Pill discontinue it
within the first
year because of side effects, the development of benign breast disease,
or some abnormality of the sexual organs. Studies of Pill usage do not
include these women, and the result is an unbalanced picture of only
the
healthiest of women who tolerate the Pill.56 This is
compared
with the general population of women who are pregnant.
The fact is that there are 13.8 million women in the
U.S. and 60 million
women worldwide who use the Pill (conservative numbers).57
And
there are 7.9 Pill-related deaths per 100,000 women ages 15-44.58
Therefore, one can calculate that there are over
1090 deaths each
year in the U.S. alone simply due to the Pill.
But I’ve heard there are no side effects with the
Pill I use.
All drugs, including all brands of the birth control
pill, have potential
side effects. There is no telling in advance how any particular woman
will
react to the Pill, but there is a good chance of some type of reaction.
It is possible that a woman will be unaware that there is any
connection
between the reaction and the Pill especially if it takes years to
manifest
itself.
Aren’t there any therapeutic benefits from the Pill?
The only "indication," or use for the Pill that is approved
by
the Food and Drug Administration is "the prevention of pregnancy in
women
. . . as a method of contraception."59 Some unapproved
uses, considered experimental, include its use as a "morning after"
pill
(causing an early abortion), and for relief from the symptoms of mild
endometriosis.60
I’m breastfeeding my baby; can I use the Pill?
No. Artificial hormones pass from breast milk to the
baby; the Pill
also decreases both the quantity and protein content of the milk
produced.61
What is my alternative to using the Pill?
Natural Family Planning (NFP) is safe, healthy and
effective and it’s
also inexpensive. A woman observes and records changes in her basal
body
temperature, the normal flow of cervical mucus, and if she wishes, the
physical changes in the cervix itself. She then cross-checks these
signs
of fertility to follow, day by day, the natural course of her fertility
cycle. No drugs, no devices, no surgical procedures, no threat of
death,
no side effects, no chemical abortions!
Does NFP really work?
Yes. Married couples can achieve a 99% effectiveness if
they learn the
method, correctly interpret the fertility signs, and follow the rules.62
One positive side benefit for couples who are committed to making this
method work is the potential for a healthier marriage —
psychologically,
physically and spiritually.63,64
— Paul Weckenbrock, R.Ph.
How can I find out more about Natural Family Planning?
Contact the national office of The Couple
to Couple League, P. O. Box 111184, Cincinnati, OH 45211; (513)
471-2000.
Reference List
1. Hatcher RA, Guest F, Stewart
F, 4 others (1988).
Hormonal Overview. Contraceptive Technology (14th ed) New
York:Irvington
Publishers 191-192. The basic information is also contained in the
package
insert. See reference 14. 2. Mishell D (Dec 1976). Current
status
of oral contraceptive steroids. Clin Ob Gyn 19 (4) 746-747. 3.
Diczfalusy E (Jan 1968). Mode of action of contraceptive drugs. Am
J
Ob Gyn 100 (1) 156-157. 4. Bronson RA (Sept 1981). Oral
contraception:
mechanism of action. Clin Ob Gyn 24 (3) 873-874. 5.
Hatcher
RA (1988) 192. 6. Harlap S, Kost K, Forrest JD (1991). Preventing
Pregnancy, Protecting Health. New York: The Alan Guttmacher
Institute,
36-37. 7. Ehmann R (Sept 1990). Problems in family planning.
Report delivered at the International Congress of the World Federation
of Doctors Who Respect Human Life. Dresden, Germany. 8. Hatcher
RA (1988). 191-192. 9. Killick S, Eyong E, Elstein M (Sept
1987).
Ovarian follicular development in oral contraceptive cycles. Fertil
Steril 48 (3), 409-413. 10. Edgren RA, Sturtevant FM (Aug
1976).
Potencies of oral contraceptives. Am J Ob Gyn 125 (8), 1030. 11.
We
are close to lowest steroid dosage in the Pill (Nov 26-30 1984). News
and Views. Excerpts from the second annual meeting of the Society
for
the Advancement of Contraception, Jakarta; edit Korteling W. Organon
International.
West Orange, NJ (U.S.). 12. Van der Vange N (1988). Ovarian
activity
during low dose oral contraceptives. Contemporary Obstetrics and
Gynecology.
Edit Chamberlin G. London: Butterworths, 315-326. 13. Peel J,
Potts
M (1969). Textbook of Contraceptive Practice. Cambridge:
Cambridge
University Press, 99. 14. Ovrette (1993) Physicians’ Desk
Reference.
Montvale, NJ: Medical Economics Co, 2606. 15. Bronson RA (Sept
1981).
869. 16. Colker R (Feb 6 1992). Louisiana abortion is a very
real
threat to women. The Dallas Morning News, 23A. 17.
Argument
by Frank Sussman, Lawyer for Missouri Abortion Clinics (Apr 27 1989). New
York Times, National Edition, 15. 18. Oral Contraceptives
(Nov
1989 insert). Edit Olin BR. Facts and Comparisons. St. Louis:
Walters
Kluwer Co., 107c-108 19. Ortho-Novum (1993). Physicians’
Desk
Reference, 1723-1730. 20. Thorogood M, Mann J, Murphy M,
Vessey
M (1991). Is oral contraceptive use still associated with an increased
risk of fatal myocardial infarction? Report of a case-control study. Br
J Ob Gyn 98, 1245-1253. 21. Thorogood M, Vessey M (1990).
An
epidemiologic survey of cardiovascular disease in women taking oral
contraceptives. Am
J Obstet Gynecol 163 (1) pt 2, 274-281. 22. Stampfer MJ,
Willett
WC, Colditz GA, Speizer FE, Hennekens CH (1990). Past use of oral
contraceptives
and cardiovascular disease: A meta-analysis in the context of the
Nurses’
Health Study. Am J Obstet Gynecol 163 (1) pt 1, 285-291. 23.
Demulen (1993). Physicians’ Desk Reference, 2254. 24.
Olsson
H, Ranstam J, Baldetorp B and 4 others (1991). Proliferation and DNA
ploidy
in malignant breast tumors in relation to early oral contraceptive use
and early abortions. Cancer 67 (5), 1285-1290. 25. U.K.
National
Case-Control Study Group (1989). Oral contraceptive use and breast
cancer
in young women. Lancet 1 (8645), 973-982. 26. Meirik O,
Lund
E, Adami H and 3 others (1986). Oral contraceptive use and breast
cancer
in young women. Lancet 2 (8508), 650-653. 27. Rushton
L,
Jones D (1992). Oral contraceptive use and breast cancer risk: a
meta-analysis
of variations with age at diagnosis, parity and total duration of oral
contraceptive use. Br J Obstet Gynecol 99, 239-46. 28.
Miller
DR, Rosenberg L, Kaufman DW and 3 others (1989). Breast cancer before
age
45 and oral contraceptive use: New Findings. Am J Epidemiol 129
(2), 269-280. 29. Pike MC, Henderson BF, Krailo MD. Duke A, Roy
S (1983). Breast cancer in young women and use of oral contraceptives.
Possible modifying effect of formulation and age at use. Lancet 2
(8356), 926-930. 30. Stadel BV, Lai S, Schlesselman JJ, Murray
P
(1988). Oral contraceptives and premenopausal breast cancer in
nulliparous
women. Contraception 38 (3), 287-299. 31. Kay CR,
Hannaford
PC (1988). Breast cancer and the Pill - A further report from the Royal
College of General Practitioners’ oral contraception study. Br J
Cancer
58, 675-680. 32. Rather D, Jones P, Moriarity E, Corderi V,
Taira
L (May 1 1991). Beating breast cancer. New York: CBS. 33.
Olsson
H, Borg A, Ferno M, Moller TR, Ranstam J (1991). Early oral
contraceptive
use and premenopausal breast cancer - A review of studies performed in
Southern Sweden. Cancer Detect Prev 15 (4), 265-271. 34.
Oral Contraceptives (Nov 1989 insert). Facts and Comparisons.
107c. 35.
Oral Contraceptives in the 1980s (May-June 1982). Population Reports.
Baltimore: Johns Hopkins University, Series A(6), A-203. 36.
Hume
K (1985). The pill and cancer. Linacre Quarterly 52 (4),
306-311. 37.
Roy S, Bernstein L, Stanczyk FZ (1988). Analysis of oral contraceptive
risks. Female contraception eds: Runnebaum B, Rabe T, Kiesel L.
Berlin-Heidelberg: Springer-Verlag 29-30. 38. Hatcher RA,
Stewart
F, Trussell J and 4 others (1990). The pill: Combined oral
contraceptives. Contraceptive
Tecnhology New York: Irvington Publishers, 243-244. 39.
Schlesselman
JJ (1989). Cancer of the breast and reproductive tract in relation to
use
of oral contraceptives. Contraception 40 (1), 20-25. 40.
Hume K (1985). 305-306. 41. Roy S (1988). 30-31. 42.
Oral
contraceptives in the 1980s (May-June 1982). Population Reports.
A-204. 43. Oral contraceptives (November 1989 insert). Facts
and Comparisons. 107e. 44. LaVecchia C, Franceschi S,
Bruzzi
P, Parazzini F, Boyle P (1990). The relationship between oral
contraception
use, cancer and vascular disease. Drug Safety 5 (6), 436-446. 45.
Hatcher RA (1990). 244. 46. Holly EA, Weiss NS, Liff JM (1983).
Cutaneous melanoma in relation to exogenous hormones and reproductive
factors. J
Natl Cancer Inst 70, 827. 47. Beral V,Evans S,Shaw
H,Milton,G
(1984). Oral contraceptive use and malignant melanoma in Australia. Br
J Cancer 50, 681-685. 48. Oral Contraceptives (Nov 1989
insert). Facts
and Comparisons. 108. 49. Murad F, Haynes RC (1985).
Estrogens
and progestins. The Pharmacological Basis of Therapeutics,
eds:Gilman
AG, Goodman LS, Rall TW, Murad F. New York: Macmillan, 1435-1436. 50.
Ehmann R (1990). 10-15. 51. Hatcher RA (1990). 237-240. 52.
Beral V (1979). Reproductive mortality. Br Med J 2, 632-634. 53.
Sachs BP, Layde PM, Rubin GL, Rochat RW (1982). Reproductive mortality
in the United States. JAMA 247 (20), 2789-2792. 54. Hatcher
RA (1990). 528. 55. Schuitemaker NWE, Gravenhorst JB, Van Geijn
HP, Dekker GA, Van Dongen PWJ (1991). Maternal mortality and its
prevention. Eur
J Obstet Gynecol Reprod Biol 42, 531-535. 56. Grant E
(1985). The bitter pill. London: Elm Tree Books, 103. 57.
Hatcher
RA (1990). 228. 58. Harlap S (1991). 98-99. 59. Demulen
(1992). Physicians’ Desk Reference, 2253. 60. Oral
Contraceptives
(Nov 1989 insert). Facts and Comparisons. 107c. 61. Oral
Contraceptives (Nov 1989 insert). Facts and Comparisons. 107g. 62.
Wade ME, McCarthy P, Braunstein GD and 5 others (1981). A randomized
prospective
study of the use-effectiveness of two methods of natural family
planning. Am
J Obstet Gynecol 141 (4) 368-376. 63. Kippley, J Kippley, S
(1991). The Art of Natural Family Planning. (3rd ed, 5th print)
Cincinnati: Couple to Couple League 59-74. 64. Tortorici, J
(1979).
Conception regulation, self-esteem, marital satisfaction among Catholic
couples: Michigan State University study. Int Rev NFP III(3)
191-205.
Copyright 2001 Couple to Couple
League, International
Bulk copies of this
pamphlet are available from the Couple
to Couple League.
http://www.ccli.org/
6/20/2004
TOP
Back
to the Info Page
Back to our home page
|